Alprenolol and Propranolol in Hyperthyroid Tachycardia
Overview
Overview
Journal
Br J Pharmacol
Publisher
Wiley
Specialty
Pharmacology
Date
1970 Sep 1
PMID
4395079
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The assessment of β-adrenoceptor blocking drugs in hyperthyroidism.
Carruthers S, Ghosal A, McDevitt D, Nelson J, Shanks R Br J Clin Pharmacol. 2012; 1(2):93-8.
PMID: 22454894 PMC: 1402445. DOI: 10.1111/j.1365-2125.1974.tb00216.x.
Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Turner P Drugs. 1974; 7(1):48-54.
PMID: 4134125 DOI: 10.2165/00003495-197407010-00004.
References
1.
Johnsson G, NORRBY A, SOLVELL L
. Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses. Acta Pharmacol Toxicol (Copenh). 1967; 25:95-105.
DOI: 10.1111/j.1600-0773.1967.tb03000.x.
View
2.
Ablad B, Brogard M, Ek L
. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh). 1967; 25:9-40.
View
3.
Turner P, Hill R
. A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs. 1968; 8(4):268-71.
DOI: 10.1002/j.1552-4604.1968.tb00104.x.
View
4.
Kofi Ekue J, Lowe D, Shanks R
. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Br J Pharmacol. 1970; 38(3):546-53.
PMC: 1702574.
DOI: 10.1111/j.1476-5381.1970.tb10596.x.
View